Urotheelcelcarcinoom - Med-Info

495-9.
83 - Friedrich MG
Friedrich MG, Pichlmeier U, Schwaibold H, Conrad S, Huland H. Long-term intravesical adjuvant
chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and
short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder
carcinoma. Eur Urol 2007; 52: 1123-9.
84 - Fujii Y
Fujii Y, Kawakami S, Koga F, Nemoto T, Kihara K. Long-term outcome of bladder papillary urothelial
neoplasms of low malignant potential. BJU Int 2003; 92: 559-62.
85 - Fujimoto N
Fujimoto N, Harada S, Terado M, Sato H, Matsumoto T. Multiple biopsies of normal-looking urothelium in
patients with superficial bladder cancer: Are they necessary? Int J Urol 2003; 10: 631-5.
86 - Furukawa J
Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M. Upper urinary tract recurrence following radical
cystectomy for bladder cancer. Int J Urol 2007: 14: 496-9.
87 - Geller NL
Geller NL, Sternberg CN, Penenberg D et al. Prognostic factors for survival of patients with advanced
urothelial tumors treated with methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy. Cancer
1991;67:1525-31.
88 - Gerharz EW
Gerharz EW, Månsson A, Hunt S, Skinner EC, Månsson W. Quality of life after cystectomy and urinary
diversion: an evidenced based analysis. J Urol 2005; 174: 1729-36.
89 - Girgin C
Girgin C, Sezer A, Deliba M, Sahin O, Oder M, Dinçel C. Impact of the level of muscle invasion in
organ-confined bladder cancer. Urol Int 2007; 78: 145-9.
90 - Glas AS
Glas AS, Roos D, Deutekom M, Zwinderman AH, Bossuyt PMM, Kurth KH. Tumor markers in the diagnosis
of primary bladder cancer. A systematic review. J Urol 2003; 169: 1975-82.
91 - Goessl C
Goessl C, Knispel HH, Miller K, Klän R. Is routine excretory urography necessary at first diagnosis of
bladder cancer? J Urol 1997; 157: 480-1.
92 - Golka K
Golka K, Wiese A, Assento G, Bolt HM. Occupational exposure and urological cancer. World J Urol 2004;
21: 382-91.
93 - Gontero P
Gontero P, Casetta G, Maso G, Sogni F, Pretti G, Zitella A et al. Phase II study to investigate the ablative
efficacy of intravesical administration of gemcitabine in intermediate-risk superficial bladder cancer (SBC).
Eur Urol 2004; 46: 339-43.
94 - Gonul II
Gonul II, Poyraz A, Unsal C, Acar C, Alkibay T. Comparison of 1998 WHO/ISUP and 1973 WHO
classifications for interobserver variability in grading of papillary urothelial neoplasms of the bladder. Urol
Int 2007; 78: 338-44.
95 - Grossman HB
Grossman HB, Natale RB, Tangen CM, et al. Neoadjuvant chemotherapy plus cystectomy compared with
cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-66.
96 - Haes J de
Richtlijn: Urotheelcarcinoom van de blaas (1.0)
09/17/12 Urotheelcarcinoom van de blaas (1.0) 69